Table of Contents

1 Study Coverage

• 1.1 Naphazoline Hydrochloride Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Naphazoline Hydrochloride Market Size Growth Rate by Product
  • 1.4.2 Eyestrain
  • 1.4.3 Conjunctival hyperemia
  • 1.4.4 Other
• 1.5 Market by End User
  • 1.5.1 Global Naphazoline Hydrochloride Market Size Growth Rate by End User
  • 1.5.2 Adult
  • 1.5.3 Children
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Naphazoline Hydrochloride Market Size
  • 2.1.1 Global Naphazoline Hydrochloride Revenue 2014-2025
  • 2.1.2 Global Naphazoline Hydrochloride Sales 2014-2025
• 2.2 Naphazoline Hydrochloride Growth Rate by Regions
  • 2.2.1 Global Naphazoline Hydrochloride Sales by Regions
  • 2.2.2 Global Naphazoline Hydrochloride Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Naphazoline Hydrochloride Sales by Manufacturers
  • 3.1.1 Naphazoline Hydrochloride Sales by Manufacturers
  • 3.1.2 Naphazoline Hydrochloride Sales Market Share by Manufacturers
  • 3.1.3 Global Naphazoline Hydrochloride Market Concentration Ratio (CR5 and HHI)
• 3.2 Naphazoline Hydrochloride Revenue by Manufacturers
  • 3.2.1 Naphazoline Hydrochloride Revenue by Manufacturers (2014-2019)
  • 3.2.2 Naphazoline Hydrochloride Revenue Share by Manufacturers (2014-2019)
• 3.3 Naphazoline Hydrochloride Price by Manufacturers
• 3.4 Naphazoline Hydrochloride Manufacturing Base Distribution, Product Types
  • 3.4.1 Naphazoline Hydrochloride Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Naphazoline Hydrochloride Product Type
  • 3.4.3 Date of International Manufacturers Enter into Naphazoline Hydrochloride Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Naphazoline Hydrochloride Sales by Product
• 4.2 Global Naphazoline Hydrochloride Revenue by Product
• 4.3 Naphazoline Hydrochloride Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Naphazoline Hydrochloride Breakdown Data by End User

6 North America

• 6.1 North America Naphazoline Hydrochloride by Countries
  • 6.1.1 North America Naphazoline Hydrochloride Sales by Countries
  • 6.1.2 North America Naphazoline Hydrochloride Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Naphazoline Hydrochloride by Product
• 6.3 North America Naphazoline Hydrochloride by End User

7 Europe

• 7.1 Europe Naphazoline Hydrochloride by Countries
  • 7.1.1 Europe Naphazoline Hydrochloride Sales by Countries
  • 7.1.2 Europe Naphazoline Hydrochloride Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Naphazoline Hydrochloride by Product
• 7.3 Europe Naphazoline Hydrochloride by End User

8 Asia Pacific

• 8.1 Asia Pacific Naphazoline Hydrochloride by Countries
  • 8.1.1 Asia Pacific Naphazoline Hydrochloride Sales by Countries
  • 8.1.2 Asia Pacific Naphazoline Hydrochloride Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Naphazoline Hydrochloride by Product
• 8.3 Asia Pacific Naphazoline Hydrochloride by End User

9 Central & South America

• 9.1 Central & South America Naphazoline Hydrochloride by Countries
  • 9.1.1 Central & South America Naphazoline Hydrochloride Sales by Countries
  • 9.1.2 Central & South America Naphazoline Hydrochloride Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Naphazoline Hydrochloride by Product
• 9.3 Central & South America Naphazoline Hydrochloride by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Naphazoline Hydrochloride by Countries
  • 10.1.1 Middle East and Africa Naphazoline Hydrochloride Sales by Countries
  • 10.1.2 Middle East and Africa Naphazoline Hydrochloride Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Naphazoline Hydrochloride by Product
• 10.3 Middle East and Africa Naphazoline Hydrochloride by End User

11 Company Profiles

• 11.1 Novartis AG
  • 11.1.1 Novartis AG Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Novartis AG Naphazoline Hydrochloride Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Novartis AG Naphazoline Hydrochloride Products Offered
  • 11.1.5 Novartis AG Recent Development
• 11.2 Allergan, Inc.
  • 11.2.1 Allergan, Inc. Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Allergan, Inc. Naphazoline Hydrochloride Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Allergan, Inc. Naphazoline Hydrochloride Products Offered
  • 11.2.5 Allergan, Inc. Recent Development
• 11.3 Meda Pharmaceuticals Inc
  • 11.3.1 Meda Pharmaceuticals Inc Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Meda Pharmaceuticals Inc Naphazoline Hydrochloride Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Meda Pharmaceuticals Inc Naphazoline Hydrochloride Products Offered
  • 11.3.5 Meda Pharmaceuticals Inc Recent Development
• 11.4 Bausch & Lomb Inc
  • 11.4.1 Bausch & Lomb Inc Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Bausch & Lomb Inc Naphazoline Hydrochloride Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Bausch & Lomb Inc Naphazoline Hydrochloride Products Offered
  • 11.4.5 Bausch & Lomb Inc Recent Development
• 11.5 Cigna
  • 11.5.1 Cigna Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Cigna Naphazoline Hydrochloride Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Cigna Naphazoline Hydrochloride Products Offered
  • 11.5.5 Cigna Recent Development
• 11.6 Similasan Corporation
  • 11.6.1 Similasan Corporation Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Similasan Corporation Naphazoline Hydrochloride Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Similasan Corporation Naphazoline Hydrochloride Products Offered
  • 11.6.5 Similasan Corporation Recent Development
• 11.7 Visine
  • 11.7.1 Visine Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Visine Naphazoline Hydrochloride Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Visine Naphazoline Hydrochloride Products Offered
  • 11.7.5 Visine Recent Development
• 11.8 Alcon
  • 11.8.1 Alcon Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Alcon Naphazoline Hydrochloride Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Alcon Naphazoline Hydrochloride Products Offered
  • 11.8.5 Alcon Recent Development
• 11.9 Viva Opti-Free
  • 11.9.1 Viva Opti-Free Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 Viva Opti-Free Naphazoline Hydrochloride Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 Viva Opti-Free Naphazoline Hydrochloride Products Offered
  • 11.9.5 Viva Opti-Free Recent Development
• 11.10 Bausch & Lomb
  • 11.10.1 Bausch & Lomb Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 Bausch & Lomb Naphazoline Hydrochloride Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 Bausch & Lomb Naphazoline Hydrochloride Products Offered
  • 11.10.5 Bausch & Lomb Recent Development
• 11.11 Systane
• 11.12 Rite Aid
• 11.13 Walgreens
• 11.14 Staples
• 11.15 Clear eyes
• 11.16 Refresh
• 11.17 Murine
• 11.18 Tears naturale
• 11.19 Genteal

12 Future Forecast

• 12.1 Naphazoline Hydrochloride Market Forecast by Regions
  • 12.1.1 Global Naphazoline Hydrochloride Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Naphazoline Hydrochloride Revenue Forecast by Regions 2019-2025
• 12.2 Naphazoline Hydrochloride Market Forecast by Product
  • 12.2.1 Global Naphazoline Hydrochloride Sales Forecast by Product 2019-2025
  • 12.2.2 Global Naphazoline Hydrochloride Revenue Forecast by Product 2019-2025
• 12.3 Naphazoline Hydrochloride Market Forecast by End User
• 12.4 North America Naphazoline Hydrochloride Forecast
• 12.5 Europe Naphazoline Hydrochloride Forecast
• 12.6 Asia Pacific Naphazoline Hydrochloride Forecast
• 12.7 Central & South America Naphazoline Hydrochloride Forecast
• 12.8 Middle East and Africa Naphazoline Hydrochloride Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Naphazoline Hydrochloride Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

The global Naphazoline Hydrochloride market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Naphazoline Hydrochloride market based on company, product type, end user and key regions.

This report studies the global market size of Naphazoline Hydrochloride in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Naphazoline Hydrochloride in these regions.
This research report categorizes the global Naphazoline Hydrochloride market by top players/brands, region, type and end user. This report also studies the global Naphazoline Hydrochloride market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Novartis AG
Allergan, Inc.
Meda Pharmaceuticals Inc
Bausch & Lomb Inc
Cigna
Similasan Corporation
Visine
Alcon
Viva Opti-Free
Bausch & Lomb
Systane
Rite Aid
Walgreens
Staples
Clear eyes
Refresh
Murine
Tears naturale
Genteal

Market size by Product
Eyestrain
Conjunctival hyperemia
Other
Market size by End User
Adult
Children

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Naphazoline Hydrochloride market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Naphazoline Hydrochloride market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Naphazoline Hydrochloride companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Naphazoline Hydrochloride submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Naphazoline Hydrochloride are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Naphazoline Hydrochloride market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.